Drug details
Camzyos (mavacamten capsules)
type of Cardiac Myosin Inhibitors
Camzyos (mavacamten) is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- fainting, and
- reduced left ventricular ejection fraction from the heart